{"transactions":[{"id":741772,"issuer":{"id":3933,"kind":"organization","name":"Parabilis Medicines, Inc."},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:52:50.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":20215,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in full upon the earlier of (i) June 9, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":20215,"derivative":{"exercise_price":20,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":20215},"source":{"system":"sec-edgar","filing":"0001193125-26-267802","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000119312526267802/ownership.xml","form_type":"4"}},{"id":919548,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, Executive Chair"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-05T01:09:06.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":222132,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option shall vest and become exercisable in 12 equal monthly installments following January 1, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date."}],"balance_after":222132,"derivative":{"exercise_price":11.94,"expiration_date":"2036-02-02","underlying":"Common Stock","underlying_shares":222132},"source":{"system":"sec-edgar","filing":"0001193125-26-038070","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000119312526038070/ownership.xml","form_type":"4"}},{"id":919547,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, Executive Chair"}}],"security":"Common Stock","published_at":"2026-02-05T01:09:06.000Z","date":"2026-02-03","kind":"sale","planned":false,"acquired":false,"shares":333,"price":12.8971,"value":4294.7343,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The Issuer has adopted a \"sell-to-cover\" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $12.88 to $12.91 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":1629254,"source":{"system":"sec-edgar","filing":"0001193125-26-038070","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000119312526038070/ownership.xml","form_type":"4"}},{"id":919546,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, Executive Chair"}}],"security":"Common Stock","published_at":"2026-02-05T01:09:06.000Z","date":"2026-02-03","kind":"sale","planned":false,"acquired":false,"shares":30186,"price":12.2573,"value":369998.8578,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The Issuer has adopted a \"sell-to-cover\" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $11.88 to $12.875 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":1629587,"source":{"system":"sec-edgar","filing":"0001193125-26-038070","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000119312526038070/ownership.xml","form_type":"4"}},{"id":919545,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Director, Executive Chair"}}],"security":"Common Stock","published_at":"2026-02-05T01:09:06.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":37522,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are represented by restricted stock units (the \"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in full on February 1, 2027, subject to the Reporting Person's continuous service with the Issuer as of such vesting date."}],"balance_after":1659773,"source":{"system":"sec-edgar","filing":"0001193125-26-038070","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000119312526038070/ownership.xml","form_type":"4"}},{"id":1280371,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-07T01:02:12.000Z","date":"2025-02-05","kind":"sale","planned":false,"acquired":false,"shares":9013,"price":3.1614,"value":28493.6982,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer has adopted a \"sell-to-cover\" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $3.00 to $3.245 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":1622251,"source":{"system":"sec-edgar","filing":"0000950170-25-015684","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000095017025015684/ownership.xml","form_type":"4"}},{"id":1280370,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-07T01:02:12.000Z","date":"2025-02-04","kind":"sale","planned":false,"acquired":false,"shares":9778,"price":2.988,"value":29216.664,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer has adopted a \"sell-to-cover\" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $2.86 to $3.07 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":1631264,"source":{"system":"sec-edgar","filing":"0000950170-25-015684","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000095017025015684/ownership.xml","form_type":"4"}},{"id":1282073,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-06T00:31:35.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":635250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable over a four-year period, at a rate of 25% on January 1, 2026, with the remaining option shares vesting in 36 equal monthly installments thereafter."}],"balance_after":635250,"derivative":{"exercise_price":2.91,"expiration_date":"2035-02-03","underlying":"Common Stock","underlying_shares":635250},"source":{"system":"sec-edgar","filing":"0000950170-25-014810","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000095017025014810/ownership.xml","form_type":"4"}},{"id":1282072,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-06T00:31:35.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":105875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are represented by restricted stock units (the \"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest over a three year period at a rate of 33% on February 2, 2026, 33% on February 1, 2027 and 34% on February 14, 2028, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date."}],"balance_after":1641042,"source":{"system":"sec-edgar","filing":"0000950170-25-014810","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000095017025014810/ownership.xml","form_type":"4"}},{"id":1388138,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-10-10T20:16:37.000Z","date":"2024-10-08","kind":"sale","planned":true,"acquired":false,"shares":5200,"price":48.0224,"value":249716.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 29, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $48.00 to $48.08, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 4,248 restricted stock units."}],"balance_after":13065,"source":{"system":"sec-edgar","filing":"0001610717-24-000504","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000161071724000504/form4.xml","form_type":"4"}},{"id":1424352,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-08-23T20:15:54.000Z","date":"2024-08-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1808,"price":44.83,"value":81052.64,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 4,248 restricted stock units."}],"balance_after":18265,"source":{"system":"sec-edgar","filing":"0001610717-24-000443","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000161071724000443/form4.xml","form_type":"4"}},{"id":1467283,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-28T21:07:50.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":15955,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the Stock Option shall vest in full on the earlier of (i) the first anniversary of June 20, 2024 or (ii) immediately prior to the Issuer's annual meeting of stockholders following the date of grant, subject to the Reporting Person continuing in service through the vesting date."}],"balance_after":15955,"derivative":{"exercise_price":37.54,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":15955},"source":{"system":"sec-edgar","filing":"0001610717-24-000377","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000161071724000377/form4.xml","form_type":"4/A","original_submission_date":"2024-06-24"}},{"id":1467282,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-28T21:07:50.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":4248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 4,248 restricted stock units (\"RSUs\")."}],"balance_after":20073,"source":{"system":"sec-edgar","filing":"0001610717-24-000377","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000161071724000377/form4.xml","form_type":"4/A","original_submission_date":"2024-06-24"}},{"id":1470747,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-24T20:20:58.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":16700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 20, 2024 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date."}],"balance_after":16700,"derivative":{"exercise_price":37.54,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":16700},"source":{"system":"sec-edgar","filing":"0001610717-24-000358","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000161071724000358/form4.xml","form_type":"4"}},{"id":1470746,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-24T20:20:58.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":4800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 4,800 restricted stock units."}],"balance_after":20625,"source":{"system":"sec-edgar","filing":"0001610717-24-000358","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000161071724000358/form4.xml","form_type":"4"}},{"id":1653659,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-02-09T02:14:25.000Z","date":"2024-02-07","kind":"sale","planned":false,"acquired":false,"shares":4457,"price":12.6198,"value":56246.4486,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer has adopted a \"sell-to-cover\" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $12.43 to $12.77 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":1535167,"source":{"system":"sec-edgar","filing":"0000950170-24-012999","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000095017024012999/ownership.xml","form_type":"4"}},{"id":1653658,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-02-09T02:14:25.000Z","date":"2024-02-06","kind":"sale","planned":false,"acquired":false,"shares":4681,"price":12.5626,"value":58805.5306,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer has adopted a \"sell-to-cover\" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $12.22 to $12.83 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":1539624,"source":{"system":"sec-edgar","filing":"0000950170-24-012999","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000095017024012999/ownership.xml","form_type":"4"}},{"id":1659137,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-05T21:21:35.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":523012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable over a four-year period, at a rate of 25% on January 1, 2025, with the remaining option shares vesting in 36 equal monthly installments thereafter."}],"balance_after":523012,"derivative":{"exercise_price":12.28,"expiration_date":"2034-02-01","underlying":"Common Stock","underlying_shares":523012},"source":{"system":"sec-edgar","filing":"0000950170-24-011253","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000095017024011253/ownership.xml","form_type":"4"}},{"id":1659136,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-02-05T21:21:35.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":87168,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are represented by restricted stock units (the \"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest over a three year period at a rate of 1/3 on February 3, 2025, 1/3 on February 2, 2026 and 1/3 on February 1, 2027, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date."}],"balance_after":87168,"source":{"system":"sec-edgar","filing":"0000950170-24-011253","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000095017024011253/ownership.xml","form_type":"4"}},{"id":1787333,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-07T00:03:48.000Z","date":"2023-09-01","kind":"exercise","planned":false,"acquired":false,"shares":11146,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 14, 2022."}],"balance_after":1851,"derivative":{"exercise_price":4.73,"exercise_date":"2022-02-09","expiration_date":"2029-08-08","underlying":"Common Stock","underlying_shares":11146},"source":{"system":"sec-edgar","filing":"0001610717-23-000260","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000161071723000260/form4.xml","form_type":"4"}},{"id":1787332,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-07T00:03:48.000Z","date":"2023-09-01","kind":"exercise","planned":false,"acquired":false,"shares":3854,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 14, 2022."}],"balance_after":9635,"derivative":{"exercise_price":1.12,"exercise_date":"2022-04-20","expiration_date":"2028-04-19","underlying":"Common Stock","underlying_shares":3854},"source":{"system":"sec-edgar","filing":"0001610717-23-000260","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000161071723000260/form4.xml","form_type":"4"}},{"id":1787331,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-09-07T00:03:48.000Z","date":"2023-09-01","kind":"sale","planned":false,"acquired":false,"shares":15000,"price":35.0667,"value":526000.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $35.00 to $35.24, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,200 restricted stock units."}],"balance_after":15825,"source":{"system":"sec-edgar","filing":"0001610717-23-000260","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000161071723000260/form4.xml","form_type":"4"}},{"id":1787330,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-09-07T00:03:48.000Z","date":"2023-09-01","kind":"exercise","planned":false,"acquired":true,"shares":11146,"price":4.73,"value":52720.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 14, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,200 restricted stock units."}],"balance_after":30825,"source":{"system":"sec-edgar","filing":"0001610717-23-000260","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000161071723000260/form4.xml","form_type":"4"}},{"id":1787329,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-09-07T00:03:48.000Z","date":"2023-09-01","kind":"exercise","planned":false,"acquired":true,"shares":3854,"price":1.12,"value":4316.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 14, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,200 restricted stock units."}],"balance_after":19679,"source":{"system":"sec-edgar","filing":"0001610717-23-000260","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000161071723000260/form4.xml","form_type":"4"}},{"id":1858921,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-12T20:16:09.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":18400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 8, 2023 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date."}],"balance_after":18400,"derivative":{"exercise_price":24.84,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":18400},"source":{"system":"sec-edgar","filing":"0001610717-23-000134","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000161071723000134/form4.xml","form_type":"4"}},{"id":1858920,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-12T20:16:09.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":5200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 5,200 Restricted Stock Units."}],"balance_after":15825,"source":{"system":"sec-edgar","filing":"0001610717-23-000134","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000161071723000134/form4.xml","form_type":"4"}},{"id":1979901,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-02T21:06:16.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":537273,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable over a four-year period, at a rate of 25% on January 1, 2024, with the remaining option shares vesting in 36 equal monthly installments thereafter."}],"balance_after":537273,"derivative":{"exercise_price":5.2,"expiration_date":"2033-03-01","underlying":"Common Stock","underlying_shares":537273},"source":{"system":"sec-edgar","filing":"0000899243-23-006735","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000089924323006735/doc4.xml","form_type":"4"}},{"id":1979900,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-02T21:06:16.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":89545,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are represented by restricted stock units (the \"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest over a three year period at a rate of 1/3 on February 5, 2024, 1/3 on February 3, 2025 and 1/3 on February 2, 2026 subject to the Reporting Person's continuous service with the Issuer as of each such vesting date."}],"balance_after":1457137,"source":{"system":"sec-edgar","filing":"0000899243-23-006735","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000089924323006735/doc4.xml","form_type":"4"}},{"id":2228056,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-17T21:03:30.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":18400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 16, 2022 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date."}],"balance_after":18400,"derivative":{"exercise_price":16.8,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":18400},"source":{"system":"sec-edgar","filing":"0001567619-22-013107","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000156761922013107/doc1.xml","form_type":"4"}},{"id":2228055,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-17T21:03:30.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":5200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 5,200 Restricted Stock Units."}],"balance_after":10625,"source":{"system":"sec-edgar","filing":"0001567619-22-013107","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000156761922013107/doc1.xml","form_type":"4"}},{"id":2414296,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-03T21:30:33.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":625000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable over a four-year period, at a rate of 25% on January 1, 2023, with the remaining option shares vesting in 36 equal monthly installments thereafter."}],"balance_after":625000,"derivative":{"exercise_price":9.22,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":625000},"source":{"system":"sec-edgar","filing":"0000899243-22-004606","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000089924322004606/doc4.xml","form_type":"4"}},{"id":2602492,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-16T23:00:31.000Z","date":"2021-08-12","kind":"grant","acquired":true,"shares":961403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable over a four-year period, at a rate of 25% on August 10, 2022, with the remaining option shares vesting in 36 equal monthly installments thereafter."}],"balance_after":961403,"derivative":{"exercise_price":9.56,"expiration_date":"2031-08-12","underlying":"Common Stock","underlying_shares":961403},"source":{"system":"sec-edgar","filing":"0000899243-21-033152","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000089924321033152/doc4.xml","form_type":"4"}},{"id":2655982,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-24T21:15:24.000Z","date":"2021-06-22","kind":"grant","acquired":true,"shares":12659,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 22, 2021 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date."}],"balance_after":12659,"derivative":{"exercise_price":32.93,"expiration_date":"2031-06-21","underlying":"Common Stock","underlying_shares":12659},"source":{"system":"sec-edgar","filing":"0001567619-21-012588","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000156761921012588/doc1.xml","form_type":"4"}},{"id":2655981,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-24T21:15:24.000Z","date":"2021-06-22","kind":"grant","acquired":true,"shares":3617,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 3,617 Restricted Stock Units."}],"balance_after":5425,"source":{"system":"sec-edgar","filing":"0001567619-21-012588","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000156761921012588/doc1.xml","form_type":"4"}},{"id":2876832,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-06T01:09:31.000Z","date":"2021-02-04","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option is early exercisable. One thirtieth (1/30th) of the shares subject to the option will vest on each monthly anniversary measured from August 9, 2019 (the \"Vesting Commencement Date\") so that 100% of the shares subject to the option will be fully vested as of two and a half years following the Vesting Commencement Date, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":12997,"derivative":{"exercise_price":4.73,"expiration_date":"2029-08-08","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001567619-21-002350","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000156761921002350/doc1.xml","form_type":"4"}},{"id":2876831,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-06T01:09:31.000Z","date":"2021-02-04","kind":"sale","acquired":false,"shares":900,"price":51.8567,"value":46671.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $51.35 to $51.99, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,808 Restricted Stock Units."}],"balance_after":1808,"source":{"system":"sec-edgar","filing":"0001567619-21-002350","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000156761921002350/doc1.xml","form_type":"4"}},{"id":2876830,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-06T01:09:31.000Z","date":"2021-02-04","kind":"sale","acquired":false,"shares":4100,"price":50.0234,"value":205095.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $50.00 to $50.485, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,808 Restricted Stock Units."}],"balance_after":2708,"source":{"system":"sec-edgar","filing":"0001567619-21-002350","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000156761921002350/doc1.xml","form_type":"4"}},{"id":2876829,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-06T01:09:31.000Z","date":"2021-02-04","kind":"exercise","acquired":true,"shares":5000,"price":4.73,"value":23650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,808 Restricted Stock Units."}],"balance_after":6808,"source":{"system":"sec-edgar","filing":"0001567619-21-002350","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000156761921002350/doc1.xml","form_type":"4"}},{"id":2882259,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-03T14:00:18.000Z","date":"2021-02-02","kind":"exercise","acquired":false,"shares":5336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is early exercisable. Twenty-five percent of the total shares subject to the option vested on the first anniversary measured from April 20, 2018 (the \"Vesting Commencement Date\") and one sixteenth (1/16th) of the shares subject to the option will vest quarterly thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":13489,"derivative":{"exercise_price":1.12,"expiration_date":"2028-04-19","underlying":"Common Stock","underlying_shares":5336},"source":{"system":"sec-edgar","filing":"0001567619-21-002062","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000156761921002062/doc1.xml","form_type":"4"}},{"id":2882258,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-03T14:00:18.000Z","date":"2021-02-02","kind":"sale","acquired":false,"shares":5336,"price":45,"value":240120.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,808 Restricted Stock Units."}],"balance_after":1808,"source":{"system":"sec-edgar","filing":"0001567619-21-002062","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000156761921002062/doc1.xml","form_type":"4"}},{"id":2882257,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-03T14:00:18.000Z","date":"2021-02-02","kind":"exercise","acquired":true,"shares":5336,"price":1.12,"value":5976.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,808 Restricted Stock Units."}],"balance_after":7144,"source":{"system":"sec-edgar","filing":"0001567619-21-002062","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000156761921002062/doc1.xml","form_type":"4"}},{"id":2912387,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-08T23:11:17.000Z","date":"2020-12-30","kind":"other","acquired":false,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On January 4, 2021, the reporting person filed a Form 4 reporting the exercise and sale of 5,336 shares of common stock.  This Form 4 was mistakenly filed due to broker error and the exercise and sale did not in fact occur."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 4, 2021, the reporting person filed a Form 4 reporting the exercise and sale of 5,336 shares of common stock.  This Form 4 was mistakenly filed due to broker error and the exercise and sale did not in fact occur."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is early exercisable. Twenty-five percent of the total shares subject to the option vested on the first anniversary measured from April 20, 2018 (the \"Vesting Commencement Date\") and one sixteenth (1/16th) of the shares subject to the option will vest quarterly thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On January 4, 2021, the reporting person filed a Form 4 reporting the exercise and sale of 5,336 shares of common stock.  This Form 4 was mistakenly filed due to broker error and the exercise and sale did not in fact occur."}],"balance_after":18825,"derivative":{"exercise_price":1.12,"expiration_date":"2028-04-19","underlying":"N/A","underlying_shares":0},"source":{"system":"sec-edgar","filing":"0001567619-21-000828","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000156761921000828/doc1.xml","form_type":"4/A","original_submission_date":"2021-01-04"}},{"id":2925866,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-05T00:50:09.000Z","date":"2020-12-30","kind":"exercise","acquired":false,"shares":5336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is early exercisable. Twenty-five percent of the total shares subject to the option vested on the first anniversary measured from April 20, 2018 (the \"Vesting Commencement Date\") and one sixteenth (1/16th) of the shares subject to the option will vest quarterly thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":13489,"derivative":{"exercise_price":1.12,"expiration_date":"2028-04-19","underlying":"Common Stock","underlying_shares":5336},"source":{"system":"sec-edgar","filing":"0001567619-21-000102","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000156761921000102/doc1.xml","form_type":"4"}},{"id":2925865,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T00:50:09.000Z","date":"2020-12-30","kind":"sale","acquired":false,"shares":100,"price":41.33,"value":4133.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,808 Restricted Stock Units."}],"balance_after":1808,"source":{"system":"sec-edgar","filing":"0001567619-21-000102","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000156761921000102/doc1.xml","form_type":"4"}},{"id":2925864,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T00:50:09.000Z","date":"2020-12-30","kind":"sale","acquired":false,"shares":5236,"price":40.9467,"value":214396.9212,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $40.27 to $41.17, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,808 Restricted Stock Units."}],"balance_after":1908,"source":{"system":"sec-edgar","filing":"0001567619-21-000102","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000156761921000102/doc1.xml","form_type":"4"}},{"id":2925863,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T00:50:09.000Z","date":"2020-12-30","kind":"exercise","acquired":true,"shares":5336,"price":1.12,"value":5976.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,808 Restricted Stock Units."}],"balance_after":7144,"source":{"system":"sec-edgar","filing":"0001567619-21-000102","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000156761921000102/doc1.xml","form_type":"4"}},{"id":3013595,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-06T00:17:03.000Z","date":"2020-10-05","kind":"exercise","acquired":false,"shares":7196,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option is early exercisable. Twenty-five percent of the total shares subject to the option vested on the first anniversary measured from April 20, 2018 (the \"Vesting Commencement Date\") and one sixteenth (1/16th) of the shares subject to the option will vest quarterly thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":18825,"derivative":{"exercise_price":1.12,"expiration_date":"2028-04-19","underlying":"Common Stock","underlying_shares":7196},"source":{"system":"sec-edgar","filing":"0001567619-20-017604","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000156761920017604/doc1.xml","form_type":"4"}},{"id":3013594,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-06T00:17:03.000Z","date":"2020-10-02","kind":"exercise","acquired":false,"shares":804,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option is early exercisable. Twenty-five percent of the total shares subject to the option vested on the first anniversary measured from April 20, 2018 (the \"Vesting Commencement Date\") and one sixteenth (1/16th) of the shares subject to the option will vest quarterly thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":26021,"derivative":{"exercise_price":1.12,"expiration_date":"2028-04-19","underlying":"Common Stock","underlying_shares":804},"source":{"system":"sec-edgar","filing":"0001567619-20-017604","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000156761920017604/doc1.xml","form_type":"4"}},{"id":3013593,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-06T00:17:03.000Z","date":"2020-10-01","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option is early exercisable. Twenty-five percent of the total shares subject to the option vested on the first anniversary measured from April 20, 2018 (the \"Vesting Commencement Date\") and one sixteenth (1/16th) of the shares subject to the option will vest quarterly thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":26825,"derivative":{"exercise_price":1.12,"expiration_date":"2028-04-19","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001567619-20-017604","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000156761920017604/doc1.xml","form_type":"4"}},{"id":3013592,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-06T00:17:03.000Z","date":"2020-10-05","kind":"sale","acquired":false,"shares":7196,"price":36.1747,"value":260313.1412,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The transaction was executed in multiple trades in prices ranging from $36.00 to $36.52, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,808 Restricted Stock Units."}],"balance_after":1808,"source":{"system":"sec-edgar","filing":"0001567619-20-017604","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000156761920017604/doc1.xml","form_type":"4"}},{"id":3013591,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-06T00:17:03.000Z","date":"2020-10-05","kind":"exercise","acquired":true,"shares":7196,"price":1.12,"value":8059.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,808 Restricted Stock Units."}],"balance_after":9004,"source":{"system":"sec-edgar","filing":"0001567619-20-017604","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000156761920017604/doc1.xml","form_type":"4"}},{"id":3013590,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-06T00:17:03.000Z","date":"2020-10-02","kind":"sale","acquired":false,"shares":804,"price":36.0193,"value":28959.5172,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $36.00 to $36.10, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,808 Restricted Stock Units."}],"balance_after":1808,"source":{"system":"sec-edgar","filing":"0001567619-20-017604","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000156761920017604/doc1.xml","form_type":"4"}},{"id":3013589,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-06T00:17:03.000Z","date":"2020-10-02","kind":"exercise","acquired":true,"shares":804,"price":1.12,"value":900.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,808 Restricted Stock Units."}],"balance_after":2612,"source":{"system":"sec-edgar","filing":"0001567619-20-017604","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000156761920017604/doc1.xml","form_type":"4"}},{"id":3013588,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-06T00:17:03.000Z","date":"2020-10-01","kind":"sale","acquired":false,"shares":2000,"price":34.7605,"value":69521.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $34.26 to $35.21, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,808 Restricted Stock Units."}],"balance_after":1808,"source":{"system":"sec-edgar","filing":"0001567619-20-017604","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000156761920017604/doc1.xml","form_type":"4"}},{"id":3013587,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-06T00:17:03.000Z","date":"2020-10-01","kind":"exercise","acquired":true,"shares":2000,"price":1.12,"value":2240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,808 Restricted Stock Units."}],"balance_after":3808,"source":{"system":"sec-edgar","filing":"0001567619-20-017604","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000156761920017604/doc1.xml","form_type":"4"}},{"id":3057442,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-14T22:30:59.000Z","date":"2020-08-13","kind":"exercise","acquired":false,"shares":333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is early exercisable. Twenty-five percent of the total shares subject to the option vested on the first anniversary measured from April 20, 2018 (the \"Vesting Commencement Date\") and one sixteenth (1/16th) of the shares subject to the option will vest quarterly thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":28825,"derivative":{"exercise_price":1.12,"expiration_date":"2028-04-19","underlying":"Common Stock","underlying_shares":333},"source":{"system":"sec-edgar","filing":"0001567619-20-015578","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000156761920015578/doc1.xml","form_type":"4"}},{"id":3057441,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-14T22:30:59.000Z","date":"2020-08-12","kind":"exercise","acquired":false,"shares":1667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is early exercisable. Twenty-five percent of the total shares subject to the option vested on the first anniversary measured from April 20, 2018 (the \"Vesting Commencement Date\") and one sixteenth (1/16th) of the shares subject to the option will vest quarterly thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":29158,"derivative":{"exercise_price":1.12,"expiration_date":"2028-04-19","underlying":"Common Stock","underlying_shares":1667},"source":{"system":"sec-edgar","filing":"0001567619-20-015578","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000156761920015578/doc1.xml","form_type":"4"}},{"id":3057440,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-14T22:30:59.000Z","date":"2020-08-13","kind":"sale","acquired":false,"shares":333,"price":28,"value":9324.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,808 Restricted Stock Units."}],"balance_after":1808,"source":{"system":"sec-edgar","filing":"0001567619-20-015578","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000156761920015578/doc1.xml","form_type":"4"}},{"id":3057439,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-14T22:30:59.000Z","date":"2020-08-13","kind":"exercise","acquired":true,"shares":333,"price":1.12,"value":372.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,808 Restricted Stock Units."}],"balance_after":2141,"source":{"system":"sec-edgar","filing":"0001567619-20-015578","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000156761920015578/doc1.xml","form_type":"4"}},{"id":3057438,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-14T22:30:59.000Z","date":"2020-08-12","kind":"sale","acquired":false,"shares":1667,"price":28,"value":46676.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,808 Restricted Stock Units."}],"balance_after":1808,"source":{"system":"sec-edgar","filing":"0001567619-20-015578","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000156761920015578/doc1.xml","form_type":"4"}},{"id":3057437,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-14T22:30:59.000Z","date":"2020-08-12","kind":"exercise","acquired":true,"shares":1667,"price":1.12,"value":1867.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,808 Restricted Stock Units."}],"balance_after":3475,"source":{"system":"sec-edgar","filing":"0001567619-20-015578","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000156761920015578/doc1.xml","form_type":"4"}},{"id":3104447,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-19T19:35:08.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":6329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 17, 2020 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date."}],"balance_after":6329,"derivative":{"exercise_price":36.57,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":6329},"source":{"system":"sec-edgar","filing":"0001567619-20-012444","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000156761920012444/doc1.xml","form_type":"4"}},{"id":3104446,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":39295,"kind":"person","name":"Weber Barbara","position":1,"cik":"0001800670","reported_name":"Weber Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-19T19:35:08.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":1808,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,808 Restricted Stock Units."}],"balance_after":1808,"source":{"system":"sec-edgar","filing":"0001567619-20-012444","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800670/000156761920012444/doc1.xml","form_type":"4"}}]}